Femasys (FEMY) Construction in Progress (2020 - 2026)
Femasys' (FEMY) quarterly Construction in Progress came in at $919412.0 in Q2 2026, up 67.65% on a YoY basis from $548426.0 in Q2 2025, and down 3.75% quarter-over-quarter from $955271.0 in Q1 2026.
Analysis
Femasys (FEMY) Construction in Progress (2020 - 2026) Analysis & Trends
Femasys (FEMY) has reported Construction in Progress for 7 consecutive years, with $919412.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Construction in Progress rose 67.65% year-over-year to $919412.0; the trailing twelve-month figure through Jun 2026 stood at $919412.0 (up 67.65% YoY), and the FY2025 full-year result was $897885.0, up 17.76% from the prior year.
- Construction in Progress retreated to $919412.0 in Q2 2026 per FEMY's latest filing, from $955271.0 in the prior quarter.
- Across five years, Construction in Progress topped out at $955271.0 in Q1 2026 and bottomed at $384888.0 in Q2 2023.
- Historically, Construction in Progress has averaged $586851.3 across 5 years, with a median of $548287.5 in 2024.
- The sharpest annual moves came in 2022 and 2023: Construction in Progress soared 204.45% in 2022, then declined 21.53% in 2023.
- Over 5 years, Construction in Progress stood at $413843.0 in 2022, then grew by 2.23% to $423077.0 in 2023, then soared by 80.21% to $762445.0 in 2024, then increased by 17.76% to $897885.0 in 2025, then rose by 2.4% to $919412.0 in 2026.
- According to Business Quant data, Construction in Progress over the past three periods registered $919412.0, $955271.0, and $897885.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | - |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | - |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | 911.00 Mn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | - |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | - |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | - |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn | 455.10 Mn |
| 10 | Femasys | 9.01 Mn | 7.57 Mn | 189,391.00 | 919,412.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 919,412.00 |
| Mar 31, 2026 | 955,271.00 |
| Dec 31, 2025 | 897,885.00 |
| Sep 30, 2025 | 687,462.00 |
| Jun 30, 2025 | 548,426.00 |
| Mar 31, 2025 | 600,551.00 |
| Dec 31, 2024 | 762,445.00 |
| Sep 30, 2024 | 548,149.00 |
| Jun 30, 2024 | 651,157.00 |
| Mar 31, 2024 | 569,723.00 |
| Dec 31, 2023 | 423,077.00 |
| Sep 30, 2023 | 394,957.00 |
| Jun 30, 2023 | 384,888.00 |
| Mar 31, 2023 | 406,588.00 |
| Dec 31, 2022 | 413,843.00 |
| Sep 30, 2022 | 503,312.00 |
| Jun 30, 2022 | 461,735.00 |
| Mar 31, 2022 | 434,443.00 |
| Dec 31, 2021 | 379,713.00 |
| Sep 30, 2021 | 268,226.00 |